Paul Tudor Jones’s Ascendis Pharma A/S ASND Stock Holding History

Paul Tudor Jones’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.43M	Buy	+16,625	New	+$3.88M	0.01%	1366
2025 Q2	–	Sell	-21,299	Closed	-$3.32M	–	3225
2025 Q1	$3.32M	Buy	+21,299	New	+$3.04M	0.01%	1013
2024 Q4	–	Sell	-25,891	Closed	-$3.87M	–	2994
2024 Q3	$3.87M	Sell	25,891 -7,484	-22%	-$1.01M	0.01%	841
2024 Q2	$4.55M	Buy	+33,375	New	+$4.54M	0.02%	693
2023 Q4	–	Sell	-3,413	Closed	-$320K	–	2353
2023 Q3	$320K	Buy	+3,413	New	+$319K	﹤0.01%	1902
2023 Q1	–	Sell	-27,476	Closed	-$3.36M	–	2386
2022 Q4	$3.36M	Sell	27,476 -4,456	-14%	-$517K	0.07%	378
2022 Q3	$3.3M	Buy	31,932 +11,118	+53%	+$1.05M	0.07%	348
2022 Q2	$1.94M	Buy	+20,814	New	+$1.96M	0.05%	531
2021 Q3	–	Sell	-8,509	Closed	-$1.12M	–	2435
2021 Q2	$1.12M	Sell	8,509 -10,353	-55%	-$1.38M	0.02%	811
2021 Q1	$2.43M	Buy	18,862 +5,990	+47%	+$910K	0.05%	436
2020 Q4	$2.15M	Buy	12,872 +8,172	+174%	+$1.35M	0.06%	398
2020 Q3	$725K	Buy	4,700 +1,575	+50%	+$226K	0.03%	680
2020 Q2	$462K	Buy	+3,125	New	+$429K	0.02%	753
2018 Q2	–	Sell	-11,705	Closed	-$766K	–	1037
2018 Q1	$766K	Buy	11,705 +4,195	+56%	+$236K	0.02%	413
2017 Q4	$301K	Buy	7,510 +1,592	+27%	+$57.9K	0.01%	799
2017 Q3	$215K	Buy	+5,918	New	+$170K	0.01%	933

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Paul Tudor Jones's ASND Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 16,625 shares worth $4.43M. The stake represents 0.01% of the portfolio and ranks #1366 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in ASND as recently as Q1 2025.

Paul Tudor Jones first reported a position in ASND in Q3 2017 and has held it in 16 quarters since. The position peaked at $4.55M in Q2 2024. 310 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Paul Tudor Jones held 16,625 shares of Ascendis Pharma A/S worth $4.43M as of Q2 2026.
Ascendis Pharma A/S was a new Paul Tudor Jones position in Q2 2026.
Ascendis Pharma A/S made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1366 holding.
Paul Tudor Jones first reported a position in Ascendis Pharma A/S in Q3 2017 and has held it in 16 quarters since.
Paul Tudor Jones's Ascendis Pharma A/S position peaked at $4.55M in Q2 2024.
310 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.